|
- 积分
- 279
- 威望
- 279
- 包包
- 128
|
Title: CD133: molecule of the moment.- V4 l) s/ X$ z, l
Author: Mizrak, D.; Brittan, M.; Alison, M. R.4 N2 `" c) \5 s. c1 k/ ~3 F X7 _
Source: J Pathol, 2008, 214(1): 3-9
" _ j! y3 C s2 r1 z6 f8 _7 |! D; ?
: y& P3 A+ A' D( |" V/ @7 WTitle: Focus on molecules: prominin-1 (CD133).
, Z) R# z* r! X: \8 i0 f$ cAuthor: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)
# S+ u! I" M4 E U9 WSource: Exp Eye Res, 2007, 85(5): 585-586# T& M, h$ e/ S0 u4 L J
7 @3 h% V. n# Q( N* WTitle: CD133.: K# i% N( R' G. Z# j+ n# W5 E( p
Author: Piechaczek, C.5 \2 ~; `: G& A6 |/ p* I
Source: J Biol Regul Homeost Agents, 2001, 15(1): 101-102
% `! P/ Q8 Z0 W" B* q7 g, U6 \, i* n5 z$ s) S+ H, Y6 b! C. F) x. N
Title: CD133 as a marker for cancer stem cells: progresses and concerns.
1 y* [$ X: n* ], r+ \- o: }9 vAuthor: Wu, Y.; Wu, P. Y.0 e& H w2 h+ c/ g
Source: Stem Cells Dev, 2009, 18(8): 1127-1134
& X8 F2 a; e& P u7 t2 D+ }, \' ?4 H" q' K( N3 G0 C
Title: Risk and benefit of CD133+ progenitors.. |! |1 }2 ~+ R& ~9 p+ S! E! N6 c1 x
Author: Ascione, R.; Madeddu, P.7 X6 N1 u7 o) v3 d9 ^
Source: Circ Res, 2009, 105(2): e29 Q9 t# I$ i `
P; r! u0 n9 z3 ^; FTitle: Targeting CD133 antigen in cancer.
8 _# t% ~! U2 M5 yAuthor: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...)
5 L7 Z% V6 _+ O- TSource: Expert Opin Ther Targets, 2009, 13(7): 823-837
6 n. i# Q& `. L2 q
: a$ {5 ^' m' y+ h3 x* UTitle: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.. n: S4 k+ U; M0 S
Author: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...): H* T% F# l8 a
Source: Neurosurgery, 2008, 62(2): 505-514, 514-515 |
|
发表于 2010-7-9 14:12
发表于 2010-7-9 22:47
rogresses and Concerns不好意思，没看到楼上的已经发了这一篇